Robb Friedman, MD, Oncology, Newton, MA, Newton-Wellesley Hospital

RobbScottFriedmanMD

Oncology Newton, MA

Hematologic Oncology

Clinical Instructor in Medicine, Harvard Medical School

Dr. Friedman is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Friedman's full profile

Already have an account?

  • Office

    Mass General Cancer Center at Newton-Wellesley
    Newton-Wellesley Hospital
    Newton, MA 02462
    Phone(617) 219-1230
  • Is this information wrong?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFELLOWSHIP
  • Georgetown University Hospital
    Georgetown University HospitalRESIDENCY
  • Georgetown University School of Medicine
    Georgetown University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2022
  • VA State Medical License
    VA State Medical License 2003 - 2004
  • CA State Medical License
    CA State Medical License 1999 - Present
  • MD State Medical License
    MD State Medical License 1998 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Publications & Presentations

PubMed

Abstracts/Posters

  • Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma
    Robb S Friedman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
    Robb S Friedman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy
    Robb S Friedman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

Hospital Affiliations